Gail Eckhardt
Impact in
- Oncology top 5%
- CAR-T cell therapy research
- Pancreatic and Hepatic Oncology Research
- Ear and Head Tumors
- Biotechnology top 5%
- Cancer Research and Treatments
Papers in
-
- Cell death mechanisms and regulation 2
- PI3K/AKT/mTOR signaling in cancer 2
- RNA modifications and cancer 2
- Oncology 7
- Cancer Treatment and Pharmacology 2
- Cancer-related Molecular Pathways 2
- Co-authors
- Michael S. Gordon (2 shared papers)Razelle Kurzrock (2 shared papers)G I Rodriguez (1 shared paper)Daniel D. Von Hoff (1 shared paper)Stuart Kaye (1 shared paper)David H. Kirn (1 shared paper)Sabine Eckhardt (1 shared paper)Ian Ganly (1 shared paper)
- Journals
- Journal of Clinical Oncology (5 papers)Annals of Oncology (3 papers)Cancer Research (3 papers)Clinical Cancer Research (1 paper)European Journal of Cancer (1 paper)
- Partner nations
- United StatesSwitzerlandBelgium
In The Last Decade
Gail Eckhardt
19 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 78
- Oncology 720
- Biotechnology 140
- Cancer Research 217
- Genetics 309
- Molecular Biology 757
Countries citing papers authored by Gail Eckhardt
This map shows the geographic impact of Gail Eckhardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gail Eckhardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gail Eckhardt more than expected).
Fields of papers citing papers by Gail Eckhardt
This network shows the impact of papers produced by Gail Eckhardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gail Eckhardt. The network helps show where Gail Eckhardt may publish in the future.
Co-authors
The 25 scholars most cited alongside Gail Eckhardt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 431 | |
| 2 | A phase I study of Onyx-015, an E1B attenuated adenovirus, administered intratumorally to patients with recurrent head and neck cancer. | 2000 | 350 |
| 3 | 2017 | 175 | |
| 4 | 2009 | 172 | |
| 5 | 1998 | 122 | |
| 6 | 2018 | 106 | |
| 7 | 2006 | 77 | |
| 8 | 2014 | 49 | |
| 9 | 2006 | 46 | |
| 10 | 2016 | 35 | |
| 11 | 2000 | 25 | |
| 12 | 2007 | 18 | |
| 13 | 2006 | 9 | |
| 14 | 2017 | 5 | |
| 15 | [HDL and LDL cholesterol changes in psychological stress in relation to stress experience]. | 1984 | 3 |
| 16 | 2013 | 2 | |
| 17 | 2017 | 1 | |
| 18 | 2009 | 1 | |
| 19 | 2018 | 1 | |
| 20 | 1997 | 0 |
About Gail Eckhardt
Gail Eckhardt is a scholar working on Molecular Biology, Oncology, Cancer Research, Biotechnology and Pulmonary and Respiratory Medicine, having authored 20 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cancer Research and Treatments (3 papers), Cancer Genomics and Diagnostics (2 papers), Cell death mechanisms and regulation (2 papers), Cancer Treatment and Pharmacology (2 papers), Cancer-related Molecular Pathways (2 papers), Lung Cancer Treatments and Mutations (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Oncology (720 citations), Biotechnology (140 citations), Cancer Research (217 citations), Genetics (309 citations) and Molecular Biology (757 citations). Gail Eckhardt has collaborated with scholars based in United States, Switzerland and Belgium. Frequent co-authors include Michael S. Gordon, Razelle Kurzrock, G I Rodriguez, Daniel D. Von Hoff, Stuart Kaye, David H. Kirn, Sabine Eckhardt, Ian Ganly, A.G. Robertson and Carla Heise. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Research, Clinical Cancer Research and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.